HU9302212D0 - Tablet-shaped preparatives being dispersible in water - Google Patents

Tablet-shaped preparatives being dispersible in water

Info

Publication number
HU9302212D0
HU9302212D0 HU9302212A HU9302212A HU9302212D0 HU 9302212 D0 HU9302212 D0 HU 9302212D0 HU 9302212 A HU9302212 A HU 9302212A HU 9302212 A HU9302212 A HU 9302212A HU 9302212 D0 HU9302212 D0 HU 9302212D0
Authority
HU
Hungary
Prior art keywords
water
dispersible
triazine
preparatives
tablet
Prior art date
Application number
HU9302212A
Other languages
Hungarian (hu)
Other versions
HUT67019A (en
HU221677B1 (en
Inventor
Kristina Elzbieta Fielden
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919102019A external-priority patent/GB9102019D0/en
Priority claimed from GB919124807A external-priority patent/GB9124807D0/en
Priority claimed from GB919124803A external-priority patent/GB9124803D0/en
Priority claimed from GB919125005A external-priority patent/GB9125005D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of HU9302212D0 publication Critical patent/HU9302212D0/en
Publication of HUT67019A publication Critical patent/HUT67019A/en
Publication of HU221677B1 publication Critical patent/HU221677B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Abstract

Water-dispersible tablets comprise a drug (I) and a swellable clay (II). The tablets disperse in water within 3 min. to form a dispersion capable of passing through a screen with a mesh size of 710 microns. (I) is selected from analgesic propionic acid derivs., tranquillising benzodiazepines, antiviral nucleoside analogues, antiprotozoal naphthoquinones, allopurinol, oxopurinol, anticonvulsant 1,2,4-triazine derivs., and trimethoprim (opt. in combination with sulphamethoxazole). Also claimed is (II) for use as a dispersing agent for water-dispersible tablets. (I) is acyclovir (GB 1523865) or lamotrigine, i.e. 3,5-diamino -6-(2,3-dichlorophenyl) -1,2,4-triazine (EP 21121 and 247929). (II) is a smectitie or attapulgite clay, pref. a montmorillonite, esp. 'Veegum F' or bentonite
HU9302212A 1991-01-30 1992-01-29 Water-dispersible tablets and process for production of them HU221677B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB919102019A GB9102019D0 (en) 1991-01-30 1991-01-30 Pharmaceutical formulations
GB919124807A GB9124807D0 (en) 1991-11-22 1991-11-22 Pharmaceutical formulations
GB919124803A GB9124803D0 (en) 1991-11-22 1991-11-22 Pharmaceutical formulations
GB919125005A GB9125005D0 (en) 1991-11-25 1991-11-25 Pharmaceutical formulations
PCT/GB1992/000163 WO1992013527A1 (en) 1991-01-30 1992-01-29 Water-dispersible tablets

Publications (3)

Publication Number Publication Date
HU9302212D0 true HU9302212D0 (en) 1993-10-28
HUT67019A HUT67019A (en) 1995-01-30
HU221677B1 HU221677B1 (en) 2002-12-28

Family

ID=27450613

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9302212A HU221677B1 (en) 1991-01-30 1992-01-29 Water-dispersible tablets and process for production of them
HU95P/P00506P HU211161A9 (en) 1991-01-30 1995-06-28 In water dispersible tablets

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU95P/P00506P HU211161A9 (en) 1991-01-30 1995-06-28 In water dispersible tablets

Country Status (37)

Country Link
US (2) US5556639A (en)
EP (1) EP0522128B1 (en)
JP (2) JP3118255B2 (en)
KR (1) KR100190254B1 (en)
AT (1) ATE133068T1 (en)
AU (2) AU653203B2 (en)
BE (1) BE1004461A5 (en)
BG (1) BG61665B2 (en)
CA (1) CA2098108C (en)
CH (1) CH685978A5 (en)
CY (1) CY2007A (en)
CZ (1) CZ286723B6 (en)
DE (2) DE69207656T2 (en)
DK (2) DK0522128T3 (en)
ES (2) ES2080641B1 (en)
FI (2) FI111605B (en)
FR (1) FR2671970B1 (en)
GB (1) GB2257363B (en)
GR (1) GR3019545T3 (en)
HK (1) HK78597A (en)
HU (2) HU221677B1 (en)
IE (1) IE77165B1 (en)
IL (1) IL100796A (en)
IT (1) IT1257473B (en)
LU (1) LU88323A1 (en)
MX (1) MX9200412A (en)
MY (2) MY110880A (en)
NL (1) NL9220009A (en)
NO (1) NO306697B1 (en)
PA (1) PA7695401A1 (en)
PL (1) PL169106B1 (en)
RU (1) RU2106861C1 (en)
SA (1) SA92120365B1 (en)
SE (1) SE9302363D0 (en)
SK (2) SK282071B6 (en)
UA (1) UA37214C2 (en)
WO (1) WO1992013527A1 (en)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424766D0 (en) * 1994-12-07 1995-02-08 Wellcome Found Pharmaceutical composition
ES2079327B1 (en) * 1994-12-13 1996-08-01 Lilly Sa PHARMACEUTICAL FORMULATIONS OF CEFACLOR.
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
GB9518465D0 (en) * 1995-09-09 1995-11-08 Smithkline Beecham Seiyaku Kk Pharmaceuticals
GB9600847D0 (en) * 1996-01-16 1996-03-20 Smithkline Beecham Plc Pharmaceuticals
FR2759706B1 (en) * 1997-02-18 2003-11-28 Alain Perrier PROCESS FOR TREATING CLAY FOR THERAPEUTIC PURPOSES AND PRODUCTS OBTAINED THEREBY
US6129932A (en) * 1997-09-05 2000-10-10 Merck & Co., Inc. Compositions for inhibiting platelet aggregation
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
DE19820801A1 (en) * 1998-05-09 1999-11-25 Gruenenthal Gmbh Oral dosage form for gatifloxacin, providing reproducible decomposition time and drug release
US6376545B1 (en) 1998-11-10 2002-04-23 Teva Pharmaceutical Industries, Ltd. Dispersible compositions containing L-DOPA ethyl ester
PE20001302A1 (en) * 1998-11-27 2000-11-30 Hoffmann La Roche PREPARATIONS OF A PHARMACEUTICAL COMBINATION CONTAINING CARVEDILOL AND HYDROCHLOROTHIAZIDE
WO2000048575A1 (en) * 1999-02-17 2000-08-24 Kyowa Hakko Kogyo Co., Ltd. Tablets and process for producing tablets
US6399591B1 (en) * 2000-01-19 2002-06-04 Yung-Shin Pharmaceutical Ind. Co., Ltd. Chargeable pharmaceutical tablets
GB0010446D0 (en) * 2000-04-28 2000-06-14 Glaxo Wellcome Kk Pharmaceutical formulation
US6555145B1 (en) * 2000-06-06 2003-04-29 Capricorn Pharma, Inc. Alternate encapsulation process and products produced therefrom
US6365209B2 (en) * 2000-06-06 2002-04-02 Capricorn Pharma, Inc. Confectionery compositions and methods of making
US6358526B1 (en) 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom
EA005497B1 (en) * 2001-01-03 2005-02-24 Берлин Хеми Аг One-day pharmaceutical composition containing brivudine
US7939102B2 (en) 2002-06-07 2011-05-10 Torrent Pharmaceuticals Ltd. Controlled release formulation of lamotrigine
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
GB0223978D0 (en) * 2002-10-15 2002-11-20 Novartis Ag Organic compound
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
WO2004082587A2 (en) * 2003-03-21 2004-09-30 Ranbaxy Laboratories Limited Stable lamotrigine pharmaceutical compositions and processes for their preparation
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
EP1700591A4 (en) 2003-12-01 2011-08-03 Takeda Pharmaceutical Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing
US8309103B2 (en) * 2004-01-22 2012-11-13 Alparis, S.A. De C.V. Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US20050244493A1 (en) * 2004-04-30 2005-11-03 Withiam Michael C Rapidly disintegrating tablets comprising calcium carbonate
US20070196477A1 (en) * 2004-04-30 2007-08-23 Withiam Michael C Rapidly dissolving tablets comprising low surface area calcium phosphates
US20050244347A1 (en) * 2004-04-30 2005-11-03 Mehra Dev K Oral care products comprising calcium phosphates
CN100340235C (en) * 2004-05-21 2007-10-03 山东绿叶制药有限公司 Montmorillonite dispersed tablet and preparation technique thereof
US20060008492A1 (en) * 2004-07-09 2006-01-12 Pablo Janowicz Composition and method for delivering chemical agent to insects
DE102004042139B4 (en) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Peroral dosage forms to achieve a retarding effect after drug intake with a meal
BRPI0606187A2 (en) * 2005-02-25 2009-06-09 Hoffmann La Roche tablets with improved drug substance dispersibility
IS7724A (en) * 2005-03-02 2006-09-03 Actavis Group Composition of tablets with rapid decomposition containing heavy magnesium carbonate
JP2009500318A (en) * 2005-06-29 2009-01-08 パナセア バイオテック リミテッド Novel sustained-release pharmaceutical composition and production method thereof
EP1906937B1 (en) 2005-07-22 2016-10-19 Rubicon Research Pvt Ltd. Novel dispersible tablet composition
BRPI0617208A2 (en) * 2005-09-30 2011-07-19 Boehringer Ingelheim Vetmed pharmaceutical preparation containing meloxicam
FR2912059B1 (en) * 2007-02-06 2013-04-05 Scras USE OF ARGILES FOR THE TREATMENT OF CELIAC DISEASE
WO2008104996A2 (en) * 2007-02-28 2008-09-04 Jubilant Organosys Limited Water dispersible pharmaceutical formulation and process for preparing the same
GB0708929D0 (en) * 2007-05-09 2007-06-20 Glaxosmithkline Consumer Healt Composition
GB0709541D0 (en) * 2007-05-17 2007-06-27 Jagotec Ag Pharmaceutical excipient
TWI547282B (en) 2007-07-02 2016-09-01 愛戴爾製藥股份有限公司 Orally disintegrating tablet compositions of lamotrigine
US20090022789A1 (en) * 2007-07-18 2009-01-22 Supernus Pharmaceuticals, Inc. Enhanced formulations of lamotrigine
WO2009063484A2 (en) * 2007-08-03 2009-05-22 Alkem Laboratories Ltd Stable pharmaceutical composition of lamotrigine
EP2100595A1 (en) * 2008-03-10 2009-09-16 The Procter and Gamble Company Compressed tablets
CN102105140B (en) * 2008-07-02 2013-10-23 巴斯夫欧洲公司 Method for coating tablets
EP2612681B1 (en) * 2010-08-31 2019-01-30 Toray Industries, Inc. Coating agent for pharmaceutical solid preparation, pharmaceutical film formulation, and coated pharmaceutical solid preparation
USD666492S1 (en) 2010-11-01 2012-09-04 Colgate-Palmolive Company Cap for a container
USD666096S1 (en) 2010-11-01 2012-08-28 Colgate-Palmolive Company Cap for a container
USD666493S1 (en) 2010-11-01 2012-09-04 Colgate-Palmolive Company Cap for a container
USD666099S1 (en) 2010-11-01 2012-08-28 Colgate-Palmolive Company Cap for a container
USD666098S1 (en) 2010-11-01 2012-08-28 Colgate-Palmolive Company Cap for a container
USD666097S1 (en) 2010-11-01 2012-08-28 Colgate-Palmolive Company Cap for a container
RU2462243C1 (en) * 2011-08-17 2012-09-27 Вемур Инвестментс Лимитед Agent for treating alcohol withdrawal syndrome
RU2558091C2 (en) * 2013-07-04 2015-07-27 Общество с ограниченной ответственностью "Трейдсервис" Dispersible tablet of dioctahedral smectite and method for producing it
WO2018071547A1 (en) * 2016-10-11 2018-04-19 Aucta Pharmaceuticals Powder for oral suspension containing lamotrigine
CN107115304B (en) * 2017-04-10 2019-02-26 浙江寿仙谷医药股份有限公司 One kind removing wall lucidum spore powder tablet and preparation method thereof
PL3720424T3 (en) * 2017-12-08 2022-12-27 F. Hoffmann-La Roche Ag Pharmaceutical formulation

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB777516A (en) * 1955-04-14 1957-06-26 Griffiths Hughes Ltd E Improvements in or relating to the production of tablets by pressure
GB837451A (en) * 1956-02-20 1960-06-15 Arner Co Inc Sustained release therapeutic composition and process of preparing same
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
US3427379A (en) * 1966-01-13 1969-02-11 Hoffmann La Roche Dextromethorphan and benzyl alcohol hard candy lozenges free from opaqueness and/or tiny entrapped air bubbles
US3567819A (en) * 1969-01-30 1971-03-02 Hoffmann La Roche Cold tablet
DE2016622A1 (en) * 1970-04-08 1971-10-21 Farbenfabriken Bayer Ag, 5090 Leverkusen Anthelmintic benzimidazole deriv
NL149711B (en) * 1970-06-15 1976-06-15 Sumitomo Chemical Co METHOD OF MANUFACTURING PILLS, AS WELL AS THE PILLS MANUFACTURED THEREFORE.
US4072535A (en) * 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
FR2183546B1 (en) * 1972-05-10 1975-06-20 Servier Lab
DE2251249A1 (en) * 1972-10-19 1974-05-02 Hoechst Ag METHOD FOR PREPARING TABLETS CONTAINING PENICILLIN COMPOUNDS
US4209513A (en) * 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
DE2416903A1 (en) * 1974-04-06 1975-10-09 Bayer Ag USE OF MELT-SPRAYED BALL-SHAPED PHENACETIN GRANULES FOR THE MANUFACTURING OF TABLETS IN THE DIRECT TABLET PROCESS
JPS5154918A (en) * 1974-10-08 1976-05-14 Nippon Kayaku Kk Jozaino seizoho
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4086335A (en) * 1975-10-29 1978-04-25 Bruscato Frank N Pharmaceutical tablets containing chitin as a disintegrant
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
GB1567392A (en) * 1977-02-22 1980-05-14 Farmaceutici Italia Daunorubicin derivatives
AU508480B2 (en) * 1977-04-13 1980-03-20 Asahi Kasei Kogyo Kabushiki Kaisha Microcrystalline cellulose excipient and pharmaceutical composition containing thesame
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
JPS54129129A (en) * 1978-03-30 1979-10-06 Sankyo Co Ltd Powdered pesticide having suppressed static electrification
DE2845326C2 (en) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Use of a specific microdisperse, amorphous, porous silica for the production of digoxin-containing tablets with a strongly accelerated release of active ingredient
DE2849494A1 (en) * 1978-11-15 1980-05-29 Voss Gunter M METHOD FOR THE PRODUCTION OF MEDICINAL FORMS
CS234018B2 (en) * 1979-06-01 1985-03-14 Wellcome Found Method of 3,5-diammino-6-1,2,4-triazine derivatives making
US4251518A (en) * 1979-07-03 1981-02-17 Ralston Purina Company Method of preparing readily disintegrable pharmaceutical compositions
JPS56127309A (en) * 1980-03-11 1981-10-06 Dai Ichi Seiyaku Co Ltd Zeolite support for ascorbic acid
JPS5711913A (en) * 1980-06-24 1982-01-21 Tsumura Juntendo Inc Preparation of hard-capsule of herb medicine
JPS5711911A (en) * 1980-06-25 1982-01-21 Tsumura Juntendo Inc Preparation of herb medicine tablet
US4304773A (en) * 1980-06-26 1981-12-08 E. R. Squibb & Sons, Inc. Novel bendroflumethiazide formulations and method
JPS5756434A (en) * 1980-09-22 1982-04-05 Kao Corp Stabilized foamable composition
EP0052076B1 (en) * 1980-11-12 1985-05-29 Ciba-Geigy Ag Fast disaggregating pharmaceutical tablet
US4369308A (en) * 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
HU189534B (en) * 1981-09-09 1986-07-28 Chinoin Rt.,Hu Process for producing new tablets containing cyclodextrin polymer as desintegrator
US4414198A (en) * 1982-04-23 1983-11-08 Joseph Michaelson Rapidly disintegrable tablet composition and method
IL68311A0 (en) * 1982-04-29 1983-07-31 Scras Modified clays,their preparation and pharmaceutical compositions containing them
GB2119355B (en) * 1982-04-29 1985-05-09 Scras Modified clays
NO832446L (en) * 1982-07-06 1984-01-30 Sterwin Ag, PROCEDURE FOR PREPARING TABLETS.
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US4600579A (en) * 1983-06-07 1986-07-15 Mallinckrodt, Inc. N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
CH658188A5 (en) * 1984-03-23 1986-10-31 Ciba Geigy Ag STORAGE STABLE QUICK DISASSEMBLING PHARMACEUTICAL PRESSELS.
US4661521A (en) * 1984-04-30 1987-04-28 Mallinckrodt, Inc. Direct tableting acetaminophen compositions
DE3505433A1 (en) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen DIRECT TABLETING AIDS
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
EP0199855A1 (en) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Tablets comprising tromethoprim and a sulfonamide
WO1987001936A1 (en) * 1985-09-25 1987-04-09 Gerhard Gergely Desintegration tablet and process for its manufacture
US4781925A (en) * 1986-03-06 1988-11-01 American Home Products Corporation Calcium supplement compressed tablets
JPS62227729A (en) * 1986-03-31 1987-10-06 Kanegafuchi Chem Ind Co Ltd Heat insulating material
AU7084587A (en) * 1986-04-01 1987-10-20 Upjohn Company, The Methylprednisolone/sodium carboxymethyl starch tablet composition
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
DE3635864A1 (en) * 1986-06-26 1988-05-05 Gerhard Gergely Process for producing effervescent granules, effervescent granules produced thereby and use thereof
US4757090A (en) * 1986-07-14 1988-07-12 Mallinckrodt, Inc. Direct tableting acetaminophen compositions
KR960001372B1 (en) * 1986-09-24 1996-01-26 예일 유니버시티 Pharmaceutical composition containing
GB8624628D0 (en) * 1986-10-14 1986-11-19 Scras Soluble/splitable tablets
US4771077A (en) * 1986-10-21 1988-09-13 American Home Products Corporation (Del.) Spray dried acetaminophen
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
DE3887179T2 (en) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmaceutical composition, pharmaceutical granules and process for their preparation.
ATE73328T1 (en) * 1987-05-08 1992-03-15 Smith Kline French Lab PHARMACEUTICAL COMPOSITIONS.
US4904477A (en) * 1987-07-08 1990-02-27 American Home Products Corporation Spray dried ibuprofen compositions
ES2026198T3 (en) * 1987-07-22 1992-04-16 Farvalsa Ag COMPOSITE BASED ON SOLID VALPROIC ACID, STABLE TO HUMIDITY AND METHOD FOR ITS PREPARATION.
JP2527973B2 (en) * 1987-08-05 1996-08-28 株式会社資生堂 Spherical clay mineral and method for producing the same
DE3806633A1 (en) * 1987-09-01 1989-03-09 Bayer Ag ANTIVIRAL MEDIUM
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
JP2537062B2 (en) * 1987-10-02 1996-09-25 株式会社資生堂 Pharmaceutical composition
US4999200A (en) * 1987-12-09 1991-03-12 Marion Laboratories Psyllium tablet composition, method of manufacture and method of use
ES2060737T3 (en) * 1988-02-25 1994-12-01 Yamanouchi Europ Bv PROCEDURE FOR PREPARING A PHARMACEUTICAL GRANULATE.
US4910023A (en) * 1988-06-09 1990-03-20 Warner-Lambert Company Drug in combination with flavor masking agent and method for making same
YU120988A (en) * 1988-06-23 1990-06-30 Lek Tovarna Farmacevtskih Process for preparing new dispersion pills of cimetidine
IT1226549B (en) * 1988-07-12 1991-01-24 Resa Farma PHARMACEUTICAL COMPOSITIONS WITH ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY FOR ORAL USE, EQUIPPED WITH EXCELLENT PALATABILITY AND FREE FROM IRRITATING EFFECTS ON MUCOSES.
YU183988A (en) * 1988-09-30 1990-08-31 Lek Tovarna Farmacevtskih Process for preparing dispersion pills of dihydroergotoxine
JPH02111620A (en) * 1988-10-21 1990-04-24 Kunimine Kogyo Kk Granule dispersible in water
US4965072A (en) * 1988-11-03 1990-10-23 Miles Inc. Granulating composition and method
US5073377A (en) * 1988-11-03 1991-12-17 Miles Inc. Method of preparing oral dosage forms with a granulating composition
JPH02145501A (en) * 1988-11-25 1990-06-05 Sanyo Chem Ind Ltd Granular biocidal composition
FI895821A0 (en) * 1988-12-07 1989-12-05 Wellcome Found PHARMACEUTICAL ACTIVE CNS FOERENINGAR.
US4925676A (en) * 1989-02-02 1990-05-15 Warner-Lambert Company Extended release gemfibrozil composition
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
EP0391851B1 (en) * 1989-04-07 1994-06-22 Ciba-Geigy Ag Concentrates of pesticidal active agents and their preparation
US4970078A (en) * 1989-05-25 1990-11-13 Aqualon Company Crosslinked carboxymethyguar tablet disintegrant
EP0490920B1 (en) * 1989-09-07 1993-12-08 Gergely, Gerhard, Dr. Pharmaceutical preparation binding with gastric acid
US5037658A (en) * 1989-09-14 1991-08-06 Hoechst-Roussel Pharmaceuticals, Inc. Direct dry compressible acetaminophen composition
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
US5136080A (en) * 1989-12-04 1992-08-04 Burroughs Wellcome Co. Nitrile compounds
JP3069665B2 (en) * 1990-03-15 2000-07-24 住友化学工業株式会社 Agricultural granular wettable powder composition
GB9012316D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9012311D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
US5087454A (en) * 1990-07-30 1992-02-11 American Home Products Corporation Ibuprofen tablet
GB9025372D0 (en) * 1990-11-22 1991-01-09 Nat Res Dev Pharmaceutical dosage forms

Also Published As

Publication number Publication date
NO932422D0 (en) 1993-07-02
CZ108293A3 (en) 1994-01-19
CY2007A (en) 1998-02-20
ES2080641A1 (en) 1996-02-01
JP3118255B2 (en) 2000-12-18
DK0522128T3 (en) 1996-02-26
ATE133068T1 (en) 1996-02-15
HU211161A9 (en) 1995-10-30
DE69207656T2 (en) 1996-10-17
DE4290300T1 (en) 1993-10-07
EP0522128B1 (en) 1996-01-17
KR930702959A (en) 1993-11-29
LU88323A1 (en) 1994-01-05
MY120025A (en) 2005-08-30
JP3483515B2 (en) 2004-01-06
CH685978A5 (en) 1995-11-30
ITRM920069A0 (en) 1992-01-30
ES2089498T3 (en) 1996-10-01
DK87893A (en) 1993-07-27
AU653203B2 (en) 1994-09-22
ES2080641B1 (en) 1996-11-01
WO1992013527A1 (en) 1992-08-20
IE920284A1 (en) 1992-07-29
CA2098108A1 (en) 1992-07-31
SK282071B6 (en) 2001-10-08
SE9302363L (en) 1993-07-08
GB2257363B (en) 1994-09-28
BG61665B2 (en) 1998-02-27
MX9200412A (en) 1992-09-01
NO306697B1 (en) 1999-12-13
GR3019545T3 (en) 1996-07-31
IT1257473B (en) 1996-01-25
SK81793A3 (en) 1994-03-09
UA37214C2 (en) 2001-05-15
AU6745494A (en) 1994-09-08
PA7695401A1 (en) 1996-05-20
AU1186392A (en) 1992-09-07
FI933401A (en) 1993-07-29
SE9302363D0 (en) 1993-07-08
KR100190254B1 (en) 1999-06-01
FI20021701A (en) 2002-09-24
EP0522128A1 (en) 1993-01-13
HK78597A (en) 1997-06-20
HUT67019A (en) 1995-01-30
IL100796A0 (en) 1992-09-06
DE69207656D1 (en) 1996-02-29
JPH06504544A (en) 1994-05-26
GB9218097D0 (en) 1992-11-04
ITRM920069A1 (en) 1993-07-30
FI933401A0 (en) 1993-07-29
FR2671970A1 (en) 1992-07-31
AU659581B2 (en) 1995-05-18
NL9220009A (en) 1993-11-01
BE1004461A5 (en) 1992-11-24
DK87893D0 (en) 1993-07-27
CZ286723B6 (en) 2000-06-14
JP2000273045A (en) 2000-10-03
US5556639A (en) 1996-09-17
MY110880A (en) 1999-06-30
NO932422L (en) 1993-07-02
SA92120365B1 (en) 2004-03-20
FR2671970B1 (en) 1995-06-23
SK282072B6 (en) 2001-10-08
RU2106861C1 (en) 1998-03-20
US5660860A (en) 1997-08-26
PL169106B1 (en) 1996-06-28
CA2098108C (en) 2001-07-03
HU221677B1 (en) 2002-12-28
IE77165B1 (en) 1997-12-03
FI111605B (en) 2003-08-29
IL100796A (en) 1998-09-24
GB2257363A (en) 1993-01-13

Similar Documents

Publication Publication Date Title
HU9302212D0 (en) Tablet-shaped preparatives being dispersible in water
EP0501975A4 (en) Antihypertensive compositions and use thereof
GR3035574T3 (en) Use of substituted benzimidazoles.
AU7748087A (en) Emergency crash cart (medical purpose)
GR3026338T3 (en) High release solid preparation, preparation and use thereof
EP0572258A3 (en) Brake release lock
IL99620A0 (en) Medical rescue system
ES2022531B3 (en) SUSPENSOR COUPLING
AU9080691A (en) Brake locking and release system
Cochrane Emergency nurses' attitudes toward the rape victim
IL103832A0 (en) Personal disposable emergency breathing system
ITTO920858A1 (en) PROCEDURE FOR THE USE OF IGNEO VOLCANO MAGMA TO MELT AND REGENER USED AND RECYCLED METALS.
Bettadapur Studies on the arildone class of antiviral agents
GB2258005B (en) Panic bolt
HRP930964B1 (en) Therapeutic triazine compounds and the use thereof
Thangavelu et al. STUDIES ON CORROSION RESISTANT OF FINISHES ON ALUMINIUM(English)
GB9114632D0 (en) Radionic transmission emergency warning alarm system
GB9222779D0 (en) (50 mm towing coupling) lock bracket
GB9107749D0 (en) Safe braking distance warning system
GB9106441D0 (en) Handbrake locking system
GB8706111D0 (en) Emergency release mechanism
GB9123763D0 (en) Emergency evacuation from aircraft and similar structures
GB8824526D0 (en) Emergency equipment release mechanism